Clinical Trial Update: A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept study investigating maintenance tasquinimod in metastatic castration-resistant prostate cancer patients non-progressing after first-lin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Tasquinimod (tasquinimod)

Snippet

Sponsor: Ipsen | Conditions: Metastatic Castrate Resistant Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-10-03